Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Concert Pharmaceuticals, Inc.

TRADE

NASDAQ: CNCEHealthcare / Biotechnology / USA
15.21-0.09-0.59%Vol 16 1961Y Perf 9.10%
Oct 18th, 2018 11:12
BID15.18 ASK15.28
Open15.30 Previous Close15.30
Pre-Market- After-Trading15.30
 - -%  - -%
Target Price
24.25 
Analyst Rating
Strong Buy 1.50
Potencial %
58.70 
Finscreener Ranking
★★★★★     68.18
Insiders Trans % 3/6/12M
-/-100/-74 
Value Ranking
★★★★★     78.50
Insiders Value % 3/6/12M
-/-100/30 
Growth Ranking
★★★★★     77.27
Insiders Shares Cnt. % 3/6/12M
-/-100/40 
Income Ranking
 —    -
Market Cap (mil)356 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
15.67 
Earnings Date
8th Nov 2018

Today's Price Range

15.1615.36

 

52wk Range

12.3330.71

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Month
14.01%
3 Months
-8.00%
6 Months
-20.85%
1 Year
9.10%
3 Years
-33.88%
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
CNCE15.21-0.0900-0.59
AAPL218.61-2.5800-1.17
GOOG1 098.76-16.9300-1.52
MSFT109.44-1.2700-1.15
XOM82.150.65000.80
WFC53.99-0.4700-0.86
JNJ138.68-0.7800-0.56
FB156.50-2.9200-1.83
GE12.340.15001.23
JPM109.52-0.3100-0.28
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 30.90
Current Ratio 33.90
Long Term Debt to Total Capital 0.31
Total Debt to Equity 0.45
Interest Coverage -6 078.50
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin67.50
EBITDA Margin68.10
Pre-tax Profit Margin-5 888.00
Profit Margin66.47
ValuationValueIndustryS&P 500US Markets
PE Ratio 3.30
PB Ratio 1.68
PS Ratios 32.11
Price to Cash Flow 3.30
Price to Free Cash Flow -11.00
Cash Flow Per Share 4.41
Price to Tangible Book1.68
Book Value per Share8.55
Enterprise Value (in ths.)146 771
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)11.02
ROE last 12 Months 78.32
Return on Assets (5Y Avg) 3.21
ROA last 12 Months 62.85
Return on Capital (5Y Avg) -
ROC last 12 Months 78.75
Return on invested Capital Q -6.49
Return on invested Capital Y68.40
Assets Turnover0.00
Receivables Turnover19.70
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)10 493
Revenue per Share 0.45
Revenue Growth 3 Years -14.45
Revenue Growth 5 Years -8.48
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.62-0.578.06
Q01 2018-0.61-0.1968.85
Q04 2017-0.18-0.26-44.44
Q03 2017-0.54-0.70-29.63
Q02 2017-0.62-0.586.45
Q01 2017-0.54-0.60-11.11
Q04 2016-0.66-0.5418.18
Q03 2016-0.64-0.5120.31
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.627.46Positive
12/2018 QR-0.679.46Positive
12/2018 FY-2.066.79Positive
12/2019 FY-2.754.18Positive
Next Report Date8th Nov 2018
Estimated EPS Next Report-0.62
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume16 196
Shares Outstanding (in ths.)23 420
Trades Count100
Dollar Volume181 992
Avg. Volume235 619
Avg. Weekly Volume124 107
Avg. Monthly Volume152 777
Avg. Quarterly Volume127 905

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

65%35%

Bearish Bullish

38%62%

Bearish Bullish

65%35%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.50
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x